Stock Analysis on Net

Colgate-Palmolive Co. (NYSE:CL)

$22.49

This company has been moved to the archive! The financial data has not been updated since July 28, 2023.

Analysis of Revenues

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Revenues as Reported

Colgate-Palmolive Co., income statement, revenues

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Oral, Personal and Home Care
Pet Nutrition
Net sales

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).


Oral, Personal and Home Care Segment Revenue
The revenue from the Oral, Personal and Home Care segment displayed a generally positive trend over the five-year period. Starting at $13,156 million in 2018, it remained relatively flat into 2019 with a slight increase to $13,168 million. Subsequently, it experienced steady growth each year, reaching $13,588 million in 2020, then $14,110 million in 2021, and $14,254 million by 2022. The growth rate appears moderate but consistent, indicating stable demand and market conditions in this segment.
Pet Nutrition Segment Revenue
The Pet Nutrition segment exhibited a robust and consistent upward trajectory throughout the period. Beginning with $2,388 million in 2018, it increased to $2,525 million in 2019, followed by a more pronounced rise to $2,883 million in 2020. This growth accelerated in the subsequent years, with revenues reaching $3,311 million in 2021 and $3,713 million in 2022. The data suggests that this segment is expanding rapidly, likely driven by increased consumer spending or market expansion in pet-related products.
Overall Net Sales
Total net sales similarly demonstrated steady growth across the reported years. From $15,544 million in 2018, net sales increased modestly to $15,693 million in 2019. They then rose to $16,471 million in 2020, $17,421 million in 2021, and $17,967 million in 2022. The growth pace is consistent, reflecting positive performance across the business portfolio.
Comparative Insights
The Pet Nutrition segment has shown the highest growth rate among the two individual segments, contributing increasingly to the overall revenue growth. Its rising contribution percentage suggests it is becoming a more significant driver of total net sales. Meanwhile, the Oral, Personal and Home Care segment, while larger in absolute terms, experienced comparatively moderate growth. The aggregate net sales progression aligns with the combined effects of these segment trends, indicating a healthy and diversified revenue base supporting steady company growth.